Discontinuation and dose reduction of rituximab in relapsing–remitting multiple sclerosis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-1459
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Discontinuation and dose reduction of rituximab in relapsing–remitting multiple sclerosis ; day:21 ; month:1 ; year:2021 ; pages:1-8
Journal of neurology ; (21.1.2021), 1-8
- Creator
-
Boremalm, Malin
Sundström, Peter
Salzer, Jonatan
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00415-021-10399-8
- URN
-
urn:nbn:de:101:1-2021042100541061254872
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:59 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Boremalm, Malin
- Sundström, Peter
- Salzer, Jonatan
- SpringerLink (Online service)
Other Objects (12)
Relapsing/remitting type 1 diabetes
Postural Control in Relapsing-Remitting Multiple Sclerosis
Endocarditis following ocrelizumab in relapsing-remitting MS
Relapsing–remitting painful ophthalmoplegia due to orbital myositis
Abnormal multisensory integration in relapsing–remitting multiple sclerosis
Prolyl oligopeptidase is inhibited in relapsing-remitting multiple sclerosis
Cellular sources of dysregulated cytokines in relapsing-remitting multiple sclerosis
Longitudinal cortical network reorganization in early relapsing–remitting multiple sclerosis
Longitudinal cortical network reorganization in early relapsing-remitting multiple sclerosis
Longitudinal cortical network reorganization in early relapsing–remitting multiple sclerosis
Correlates and trajectories of relapses in relapsing–remitting multiple sclerosis
Rituximab for the treatment of relapsing-remitting multiple sclerosis in Thailand: an economic evaluation and budget impact analysis
Relapsing/remitting type 1 diabetes
Postural Control in Relapsing-Remitting Multiple Sclerosis
Endocarditis following ocrelizumab in relapsing-remitting MS
Relapsing–remitting painful ophthalmoplegia due to orbital myositis
Abnormal multisensory integration in relapsing–remitting multiple sclerosis
Prolyl oligopeptidase is inhibited in relapsing-remitting multiple sclerosis
Cellular sources of dysregulated cytokines in relapsing-remitting multiple sclerosis
Longitudinal cortical network reorganization in early relapsing–remitting multiple sclerosis
Longitudinal cortical network reorganization in early relapsing-remitting multiple sclerosis
Longitudinal cortical network reorganization in early relapsing–remitting multiple sclerosis
Correlates and trajectories of relapses in relapsing–remitting multiple sclerosis
Rituximab for the treatment of relapsing-remitting multiple sclerosis in Thailand: an economic evaluation and budget impact analysis
Relapsing/remitting type 1 diabetes
Postural Control in Relapsing-Remitting Multiple Sclerosis
Endocarditis following ocrelizumab in relapsing-remitting MS
Relapsing–remitting painful ophthalmoplegia due to orbital myositis
Abnormal multisensory integration in relapsing–remitting multiple sclerosis
Prolyl oligopeptidase is inhibited in relapsing-remitting multiple sclerosis
Cellular sources of dysregulated cytokines in relapsing-remitting multiple sclerosis
Longitudinal cortical network reorganization in early relapsing–remitting multiple sclerosis
Longitudinal cortical network reorganization in early relapsing-remitting multiple sclerosis
Longitudinal cortical network reorganization in early relapsing–remitting multiple sclerosis
Correlates and trajectories of relapses in relapsing–remitting multiple sclerosis